Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $16.3600 (-0.12%) ($16.2000 - $16.6800) on Mon. Dec. 19, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 61 | Latest Price | $16.3600(-0.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SGEN declines -1% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IWM(34%) QQQ(33%) SPY(33%) XLK(29%) XLY(27%) | Factors Impacting SGEN price | SGEN will decline at least -1.79% in a week (0% probabilities). TLT(-11%) SHY(-4%) TIP(-2%) IGOV(-1%) LQD(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $16.49 | 5 Day Moving Average | $16.5(-0.85%) | 10 Day Moving Average | $16.97(-3.59%) | 20 Day Moving Average | $16.49(-0.79%) | To recent high | -26.6% | To recent low | 8.9% | Market Cap | $2.844b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |